Scientific Sessions 2024  /  Stroke Council Award and Keynote Lecture  /  Atrial Cardiopathy and Cryptogenic Stroke
Logo

American Heart Association

  140
  0

Final ID:

Atrial Cardiopathy and Cryptogenic Stroke

  • Kamel, Hooman  ( Weill Cornell Medicine , New York , New York , United States )
    • Author Disclosures:
    Hooman Kamel: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Financial disclosures for Hooman Kamel: a PI role in the ARCADIA trial, which received in-kind study drug from the BMS-Pfizer Alliance for Eliquis and ancillary study support from Roche Diagnostics; a Deputy Editor role for JAMA Neurology; clinical trial steering/executive committee roles for the STROKE-AF (Medtronic), LIBREXIA-AF (Janssen), and LAAOS-4 (Boston Scientific) trials; consulting or endpoint adjudication committee roles for AbbVie, AstraZeneca, Boehringer Ingelheim, and Novo Nordisk; and household ownership interests in TETMedical, Spectrum Plastics Group, and Ascential Technologies.:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Stroke Council Award and Keynote Lecture

Monday, 11/18/2024 , 08:00AM - 09:15AM

Abstract Oral Session

More abstracts on this topic:
Depression Symptomatology as Predictor of Incident Major Vascular Outcomes: Results from the Hispanic Community Health Study/Study of Latinos

Trifan Gabriela, Daviglus Martha, Pirzada Amber, Testai Fernando, Gallo Linda, Lamar Melissa, Wassertheil-smoller Sylvia, Gonzalez Hector, Perreira Krista, Cai Jianwen, Rundek Tatjana, Levin Bonnie

Neuro-specific biomarkers for risk assessment of ischemic stroke and death in patients with atrial fibrillation not receiving oral anticoagulation

Aulin Julia, Sjolin Karl, Lindback Johan, Benz Alexander, Eikelboom John, Oldgren Jonas, Wallentin Lars, Burman Joachim

More abstracts from these authors:
The Trouble with ESUS: What do the studies tell us? Where do we do from here?

Kamel Hooman, Messe Steven

The Next Generation of Clinical Trials in Stroke Prevention: Crossing Borders

Kelly Peter, Kamel Hooman

You have to be authorized to contact abstract author. Please, Login
Not Available